2nd iPSC-Derived Cell Therapies Summit
December 6 @ 8:00 am - December 7 @ 5:00 pm
A new era of cell therapy has well and truly arrived, with the iPSC field setting a trailblazing fire with its potential to develop fully scalable, off-the-shelf cell lines reducing the cost of goods and increasing accessibility to patients.
As the iPSC field continues to grow, advance and harness excitement, the flagship iPSC-Derived Cell Therapies Summit is reuniting industry leaders for the second time to tackle the challenges impeding development. Over two days and two tracks of content, you’ll hear exclusive case studies, latest updates and innovations with industry pioneers such as Century Therapeutics, Healios K.K., Sana Biotechnology, Takeda and many more.
The industry-trusted 2nd iPSC-Derived Cell Therapies Summit provides a dedicated forum to voice challenges, collaborate and spark conversations with the community committed to advancing iPSC-derived treatments. Explore approaches to boost safe gene-editing, approach regulatory affairs, turbocharge scale-up, optimize analytics and more to produce best-in-class therapies for immuno-oncology and regenerative medicine. Take home new learnings and key insights from your peers to create high-quality, scalable, and affordable therapies.
After the success of last year, in 2022 we look forward to:
Brand New CMC & Regulatory Track
30+ Expert Speakers
12 New Speaking Companies
Join us in Boston this December to progress development with the industry’s trailblazers
- December 6 @ 8:00 am
- December 7 @ 5:00 pm
- Organizer Name
- Isabella Maxton
- Contact Email Address